No Picture
News

Histogen to Present at the Canaccord Genuity 41st Annual Growth Conference

SAN DIEGO, July 29, 2021 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, today announced that Richard W. Pascoe, President and Chief Executive Officer of Histogen,… Click here to view original post… […]

No Picture
Uncategorized

Senior Scientist – Genomic Applications & Collaborations – Omniome Inc. – San Diego, CA

The Scientist will be required to work cross-functionally within the organization including the bioinformatics, engineering, biochemistry and commercial…From Omniome Inc. – Fri, 30 Jul 2021 23:44:25 GMT – View all San Diego, CA jobsClick here […]

No Picture
News

Halozyme to Participate in Canaccord Genuity 41st Annual Growth Conference

SAN DIEGO: SAN DIEGO, July 30, 2021 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Elaine Sun, senior vice president and chief financial officer, will virtually represent the company in a fireside chat at the Canaccord Genuity 41st Annual Growth Conference Securities 2021 Virtual Health Care Conference on… Click here to view original post… […]

No Picture
News

Oncternal Therapeutics to Provide Business Update and Report Second Quarter 2021 Financial Results

SAN DIEGO, July 29, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that it will report second quarter 2021 financial results after the U.S. financial markets close on Thursday, August 5, 2021. Oncternal’s management will host a… Click here to view original post… […]

No Picture
News

Explora BioLabs Opens New Facility in San Carlos, Calif.

SAN CARLOS, Calif.: SAN CARLOS, Calif., July 29, 2021 /PRNewswire/ — Explora BioLabs, a national provider of industry-leading preclinical vivarium research space and management services based in San Diego, opened a new facility in the San Francisco Bay region on July 26, 2021. The facility, located in San Carlos between… Click here to view original post… […]

No Picture
News

Ionis completes enrollment in pivotal NEURO-TTRansform study of eplontersen

CARLSBAD, Calif.: CARLSBAD, Calif., July 29, 2021 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapies, today announced it has completed enrollment of NEURO-TTRansform, the company’s Phase 3 study of eplontersen, formerly AKCEA-TTR-LRx, for people with hereditary transthyretin-mediated amyloid polyneuropathy (hATTR-PN). The company has exceeded the enrollment… Click here to view original post… […]

No Picture
News

NuVasive Announces Second Quarter 2021 Financial Results

SAN DIEGO: SAN DIEGO, July 28, 2021 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter ended June 30, 2021. Second Quarter 2021 Highlights Net sales increased 44.8% to… Click here to view original post… […]

No Picture
News

Viking Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update

SAN DIEGO: SAN DIEGO, July 28, 2021 /PRNewswire/ — Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced its financial results for the second quarter and six months ended June 30, 2021, and provided an… Click here to view original post… […]

No Picture
News

Heron Therapeutics Announces Publication of Results from HOPE (Helping Opioid Prescription Elimination), Showing ZYNRELEF™ Minimizes the Need for Opioids in a Real-World Setting, With 95% of Patients Experiencing an Opioid-free Recovery

SAN DIEGO: SAN DIEGO, July 28, 2021 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced the results from the HOPE Hernia-1 study of ZYNRELEF… Click here to view original post… […]

No Picture
News

Obesity and Cardiovascular Factors Combine to Cause Cognitive Decline in Latinos

Obesity is a major public health issue among Latinos, and a risk factor for Alzheimer’s disease. But in a new study, researchers at UC San Diego report that cardiometabolic abnormalities, such as hypertension, are more strongly associated with cognitive decline than obesity alone. Click here to view original post… […]

No Picture
News

Biotech Networks Hosts First Virtual Career Fair Focused on Improving Diversity in California’s Life Science Industry

Biotech Networks, the premier life science organization catalyzing connections between thousands of professionals in the field globally, is hosting the first virtual career fair focused on improving diversity in California’s life science industry. Biotech Networks […]

No Picture
News

Debut Biotech and DIC Enter into Joint Development to Biomanufacture Natural, Sustainable Colors

SAN DIEGO: SAN DIEGO, July 28, 2021 /PRNewswire-PRWeb/ — Today, Debut Biotech, a next generation biomanufacturing platform harnessing cell-free enzymes announced entry into a joint development with DIC, a fine chemicals company. The multi-million dollar deal, spanning several years, will enable Debut Biotech and DIC to leverage advanced biomanufacturing approaches… Click here to view original post… […]

No Picture
News

PYC Therapeutics Highlights Advancement of Ocular and CNS Development Programs And Continued U.S. Expansion in Second Quarter 2021 Update

SAN DIEGO and PERTH, Australia: SAN DIEGO and PERTH, Australia, July 28, 2021 /PRNewswire/ — PYC Therapeutics (ASX: PYC), a biotechnology company combining two complementary platform technologies (selective drug delivery and precision drug design) to develop a new generation of RNA therapeutics to change the lives of patients with inherited… Click here to view original post… […]

No Picture
News

Bluebird Bio and Resilience Announce Strategic Alliance to Develop Next Generation Cell Therapies

SAN DIEGO & BOSTON & CAMBRIDGE, Mass.–(BUSINESS WIRE)–National Resilience, Inc. (Resilience) and bluebird bio, Inc. (NASDAQ: BLUE), today announced a strategic alliance aimed to accelerate the early research, development and delivery of cell therapies. As part of the agreement, Resilience will acquire bluebird’s Research Triangle (bRT) manufacturing facility located in… Click here to view original post… […]

No Picture
News

PathO3Gen Solutions Introduces Innovative UVZone Disinfection Technology at Left of Boom VII Conference

ST PETERSBURG, Fla.: ST PETERSBURG, Fla., July 28, 2021 /PRNewswire/ — PathO3Gen Solutions presented multi-patented Ozone + UVC UVZone Disinfection Technology at the Seventh annual Left of Boom VII conference this month, developed by Intelligence Research Institute (IRI) and hosted by the Center for Information Convergence and Strategy (CICS) at… Click here to view original post… […]

No Picture
News

Cidara Therapeutics to Present New Data for Rezafungin at the International Society for Human and Animal Mycology (ISHAM) Asia Congress

SAN DIEGO, July 27, 2021 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections, today announced that it will present clinical and pre-clinical data, including updated analyses from the… Click here to view original post… […]

No Picture
News

Halozyme To Host Second Quarter 2021 Financial Results Webcast and Conference Call

SAN DIEGO: SAN DIEGO, July 27, 2021 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the second quarter 2021 on Monday, August 9 at 4:30 p.m. ET / 1:30 p.m. PT. Dr. Helen Torley, president and chief executive officer, will lead the call…. Click here to view original post… […]

No Picture
News

Biotech Networks Hosts First Virtual Career Fair Focused on Improving Diversity in California’s Life Science Industry

SAN DIEGO and SAN FRANCISCO: SAN DIEGO and SAN FRANCISCO, July 27, 2021 /PRNewswire-PRWeb/ — Biotech Networks, the premier life science organization catalyzing connections between thousands of professionals in the field globally, is hosting the first virtual career fair focused on improving diversity in California’s life science industry. Biotech Networks… Click here to view original post… […]

No Picture
News

Novo Holdings Leads US$ 118M Series C Investment in Genomatica

COPENHAGEN, Denmark and SAN DIEGO: COPENHAGEN, Denmark and SAN DIEGO, July 27, 2021 /PRNewswire/ — Novo Holdings, a leading international life science investor, today announces that it has led the US$ 118M Series C financing in new portfolio company Genomatica, which harnesses biology to remake everyday products and materials with… Click here to view original post… […]

No Picture
News

Steven P. Cohen, Chief of Pain Medicine at Johns Hopkins, Joins Releviate Therapeutics as Head of Its Scientific Advisory Board

SAN DIEGO–(BUSINESS WIRE)–Releviate™ Therapeutics, a bio-pharmaceutical company developing a novel human antibody-based approach to treating neuropathic pain by potentially reversing the underlying pathophysiology of that pain, today appoints Dr. Steven P. Cohen to lead its scientific advisory board. The announcement follows Releviate Therapeutics closing its round of Series A funding…. Click here to view original post… […]

No Picture
News

UC San Diego Health Ranked #1 by U.S. News & World Report

UC San Diego Health, the region’s only academic health system, is ranked #1 in San Diego and #5 in California, placing it among the nation’s best hospitals, according to the 2021-2022 U.S. News & World Report survey. UC San Diego Health was ranked in the top… Click here to view original post… […]